InvestorsHub Logo
Followers 9
Posts 290
Boards Moderated 0
Alias Born 01/28/2014

Re: None

Thursday, 07/28/2016 1:03:02 PM

Thursday, July 28, 2016 1:03:02 PM

Post# of 229
The company plans to manage production within excess capacity in existing facilities, and expects sales of prothioconazole to generate USD100 million in revenue at prevailing market prices with gross margins reaching 40% at scale.

http://finance.yahoo.com/news/delta-technology-holdings-limited-announces-131500363.html